Several children who had aggressive recurrent tumors remained disease-free years after the treatment, according to an early ...
The Chosun Ilbo on MSN
Immune therapy extends survival in refractory pediatric brain tumor patients
Initial clinical results showed that three pediatric and adolescent brain tumor patients, whose conditions did not respond to ...
The long-term results from the clinical trial saw patients survive well past the usual survival time for these types of ...
An experimental immunotherapy has beaten aggressive brain tumours in a handful of children, and a personalised version is now ...
A postage stamp-sized implant eliminates a dangerous waiting period that has long worsened outcomes for cancer patients.
4don MSN
First-in-human immunotherapy more than doubles progression-free survival in glioblastoma patients
Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most challenging cancers to treat ...
A novel immunotherapy could lead to a brain cancer breakthrough after showing promising results against glioblastoma, the ...
The need for new treatments is particularly urgent. Glioblastoma remains among the most lethal cancers, with most patients ...
A type of immunotherapy has shown promising results in targeting the deadliest type of brain cancer, researchers say.
When doctors diagnosed Dr. Barbara Tucker with a rare brain cancer in 2020, they couldn’t promise she would live to see her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results